Longeveron LGVN
NASDAQ LGVN
$0.84 +0.02 (+2.02%)
At close: Aug 21, 2026 · 4:00 PM EDT

Longeveron (LGVN) Total Liabilities (2021 - 2026)

Longeveron (LGVN) posted quarterly Total Liabilities of $5.2 million for Q1 2026, up 40.46% year-over-year from $3.7 million in Q1 2025, and up 13.02% quarter-over-quarter from $4.6 million in Q4 2025.

Longeveron (LGVN) Total Liabilities (2021 - 2026) Analysis & Trends

Longeveron's Total Liabilities history runs 6 years deep, the most recent figure standing at $5.2 million for Q1 2026.

  • In Q1 2026, Total Liabilities rose 40.46% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $5.2 million (up 40.46% YoY), while the FY2025 annual figure was $4.6 million, up 24.93% from the prior year.
  • Total Liabilities for Q1 2026 stood at $5.2 million, up from $4.6 million in the prior quarter.
  • The five-year high for Total Liabilities was $6.9 million in Q4 2022, with the low at $3.7 million in Q4 2024.
  • The 5-year median for Total Liabilities is $5.1 million (2023), against an average of $5.1 million.
  • The sharpest annual moves came in 2025 and 2026: Total Liabilities sank 44.56% in 2025, then jumped 40.46% in 2026.
  • Longeveron's Total Liabilities stood at $6.9 million in 2022, then slipped by 22.76% to $5.3 million in 2023, then tumbled by 31.22% to $3.7 million in 2024, then climbed by 24.93% to $4.6 million in 2025, then climbed by 13.02% to $5.2 million in 2026.
  • Business Quant data shows LGVN's Total Liabilities at $5.2 million in Q1 2026, $4.6 million in Q4 2025, and $5.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.62 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 4.20 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 4.00 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 4.20 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 3.22 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.35 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 10.03 Bn
10 Longeveron 26.51 Mn 16.41 Mn 182,000.00 5.09 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 5.09 Mn
Mar 31, 2026 5.18 Mn
Dec 31, 2025 4.59 Mn
Sep 30, 2025 5.59 Mn
Jun 30, 2025 4.09 Mn
Mar 31, 2025 3.69 Mn
Dec 31, 2024 3.67 Mn
Sep 30, 2024 4.28 Mn
Jun 30, 2024 4.48 Mn
Mar 31, 2024 6.66 Mn
Dec 31, 2023 5.34 Mn
Sep 30, 2023 4.99 Mn
Jun 30, 2023 5.83 Mn
Mar 31, 2023 5.49 Mn
Dec 31, 2022 6.91 Mn
Dec 31, 2021 5.31 Mn